Total Revenue of $93.4 Million for the Third Quarter of 2024, Reflecting 18% Growth Over the Third Quarter of 2023? ?NDA Submission for Brensocatib in Bronchiectasis Remains on Track for the ...

ARIKAYCE is delivered by a novel inhalation device, the Lamira ® Nebulizer System, developed by PARI. Lamira ® is a quiet, portable nebulizer that enables efficient aerosolization of ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

some of the benefits of newer nebulizers include: The ability to deliver respiratory medications in smaller particle sizes (mass median diameter of particles <3–5 microns; e.g., Pari LC Sprint ...

It’s delivered via Pari Pharma’s eFlow nebulizer technology. The company announced earlier this year that the IMPALA-2 trial had met its primary endpoint and multiple secondary endpoints.

Molgramostim is delivered via an investigational eFlow ® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine ...

The trucks have lumbered through the capital for years, dumping loads of hot, acrid ash from thousands of tons of incinerated ...

University of Karachi (KU) Pharmacy Department students have developed what they claim is the world's smallest rechargeable nebulizer in an effort to make treatment for respiratory illnesses more ...

The NE-U22V MicroAir®, the world’s smallest nebulizer utilizing Vibrating Mesh Technology (V.M.T.), efficiently delivers solution medications for patients suffering from asthma, COPD or other ...

Several devices are available to create the drug aerosol particles. These include jet nebulizers, ultrasonic nebulizers, metered-dose inhalers, and dry powder inhalers through which particles can ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will be attending the ...